Cargando…

Iterative Tyrosine Phosphorylation Controls Non-canonical Domain Utilization in Crk

Crk, the prototypical member of a class of SH2 and SH3 domain-containing proteins that controls the coordinated assembly of signaling complexes, is regulated by phosphorylation of Y221 in the linker region, which forms an intramolecular SH2-pY221 auto-clamp to interrupt SH2-SH3N signaling. Here, we...

Descripción completa

Detalles Bibliográficos
Autores principales: Sriram, Ganapathy, Jankowski, Wojciech, Kasikara, Canan, Reichman, Charles, Saleh, Tamjeed, Nguyen, Khanh-Quynh, Li, Jing, Hornbeck, Peter, Machida, Kazuya, Liu, Tong, Li, Hong, Kalodimos, Charalampos G., Birge, Raymond B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4706174/
https://www.ncbi.nlm.nih.gov/pubmed/25381819
http://dx.doi.org/10.1038/onc.2014.361
_version_ 1782409128798322688
author Sriram, Ganapathy
Jankowski, Wojciech
Kasikara, Canan
Reichman, Charles
Saleh, Tamjeed
Nguyen, Khanh-Quynh
Li, Jing
Hornbeck, Peter
Machida, Kazuya
Liu, Tong
Li, Hong
Kalodimos, Charalampos G.
Birge, Raymond B.
author_facet Sriram, Ganapathy
Jankowski, Wojciech
Kasikara, Canan
Reichman, Charles
Saleh, Tamjeed
Nguyen, Khanh-Quynh
Li, Jing
Hornbeck, Peter
Machida, Kazuya
Liu, Tong
Li, Hong
Kalodimos, Charalampos G.
Birge, Raymond B.
author_sort Sriram, Ganapathy
collection PubMed
description Crk, the prototypical member of a class of SH2 and SH3 domain-containing proteins that controls the coordinated assembly of signaling complexes, is regulated by phosphorylation of Y221 in the linker region, which forms an intramolecular SH2-pY221 auto-clamp to interrupt SH2-SH3N signaling. Here, we show using LC-MS/MS and by generating phosphospecific antibodies that, iteratively with Y221, the Crk SH3C is routinely phosphorylated on Y239 and/or Y251 by several extracellular stimuli known to engage Crk. While phosphorylation at Y221 auto-inhibits the Crk SH2, phosphorylation of the SH3C generates an unconventional phosphoSH3C-SH3N unit in which the SH3N is fully functional to bind Polyproline Type II (PPII) ligands and the phosphoSH3C binds de novo to other SH2 domains. Using high throughput SH2 domain profiling, artificial neural network and position-specific scoring matrix based bio-informatics approaches, and unbiased MS, we found that the phosphoSH3C binds several SH2 domain-containing proteins, including specific non-receptor tyrosine kinases - Abl via pY251 and Csk via pY239. Functionally, we show that the phosphoSH3C modulates the Abl-mediated phenotypes of cell spreading and motility. Together, these studies describe a versatile mechanism wherein phosphorylation of Crk at Y221 is not an off switch but redirects signaling from the SH2-SH3N axis to a phosphoSH3C-SH3N axis, with the SH3N as a common denominator.
format Online
Article
Text
id pubmed-4706174
institution National Center for Biotechnology Information
language English
publishDate 2014
record_format MEDLINE/PubMed
spelling pubmed-47061742016-02-06 Iterative Tyrosine Phosphorylation Controls Non-canonical Domain Utilization in Crk Sriram, Ganapathy Jankowski, Wojciech Kasikara, Canan Reichman, Charles Saleh, Tamjeed Nguyen, Khanh-Quynh Li, Jing Hornbeck, Peter Machida, Kazuya Liu, Tong Li, Hong Kalodimos, Charalampos G. Birge, Raymond B. Oncogene Article Crk, the prototypical member of a class of SH2 and SH3 domain-containing proteins that controls the coordinated assembly of signaling complexes, is regulated by phosphorylation of Y221 in the linker region, which forms an intramolecular SH2-pY221 auto-clamp to interrupt SH2-SH3N signaling. Here, we show using LC-MS/MS and by generating phosphospecific antibodies that, iteratively with Y221, the Crk SH3C is routinely phosphorylated on Y239 and/or Y251 by several extracellular stimuli known to engage Crk. While phosphorylation at Y221 auto-inhibits the Crk SH2, phosphorylation of the SH3C generates an unconventional phosphoSH3C-SH3N unit in which the SH3N is fully functional to bind Polyproline Type II (PPII) ligands and the phosphoSH3C binds de novo to other SH2 domains. Using high throughput SH2 domain profiling, artificial neural network and position-specific scoring matrix based bio-informatics approaches, and unbiased MS, we found that the phosphoSH3C binds several SH2 domain-containing proteins, including specific non-receptor tyrosine kinases - Abl via pY251 and Csk via pY239. Functionally, we show that the phosphoSH3C modulates the Abl-mediated phenotypes of cell spreading and motility. Together, these studies describe a versatile mechanism wherein phosphorylation of Crk at Y221 is not an off switch but redirects signaling from the SH2-SH3N axis to a phosphoSH3C-SH3N axis, with the SH3N as a common denominator. 2014-11-10 2015-08-06 /pmc/articles/PMC4706174/ /pubmed/25381819 http://dx.doi.org/10.1038/onc.2014.361 Text en http://www.nature.com/authors/editorial_policies/license.html#terms Users may view, print, copy, and download text and data-mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use:http://www.nature.com/authors/editorial_policies/license.html#terms
spellingShingle Article
Sriram, Ganapathy
Jankowski, Wojciech
Kasikara, Canan
Reichman, Charles
Saleh, Tamjeed
Nguyen, Khanh-Quynh
Li, Jing
Hornbeck, Peter
Machida, Kazuya
Liu, Tong
Li, Hong
Kalodimos, Charalampos G.
Birge, Raymond B.
Iterative Tyrosine Phosphorylation Controls Non-canonical Domain Utilization in Crk
title Iterative Tyrosine Phosphorylation Controls Non-canonical Domain Utilization in Crk
title_full Iterative Tyrosine Phosphorylation Controls Non-canonical Domain Utilization in Crk
title_fullStr Iterative Tyrosine Phosphorylation Controls Non-canonical Domain Utilization in Crk
title_full_unstemmed Iterative Tyrosine Phosphorylation Controls Non-canonical Domain Utilization in Crk
title_short Iterative Tyrosine Phosphorylation Controls Non-canonical Domain Utilization in Crk
title_sort iterative tyrosine phosphorylation controls non-canonical domain utilization in crk
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4706174/
https://www.ncbi.nlm.nih.gov/pubmed/25381819
http://dx.doi.org/10.1038/onc.2014.361
work_keys_str_mv AT sriramganapathy iterativetyrosinephosphorylationcontrolsnoncanonicaldomainutilizationincrk
AT jankowskiwojciech iterativetyrosinephosphorylationcontrolsnoncanonicaldomainutilizationincrk
AT kasikaracanan iterativetyrosinephosphorylationcontrolsnoncanonicaldomainutilizationincrk
AT reichmancharles iterativetyrosinephosphorylationcontrolsnoncanonicaldomainutilizationincrk
AT salehtamjeed iterativetyrosinephosphorylationcontrolsnoncanonicaldomainutilizationincrk
AT nguyenkhanhquynh iterativetyrosinephosphorylationcontrolsnoncanonicaldomainutilizationincrk
AT lijing iterativetyrosinephosphorylationcontrolsnoncanonicaldomainutilizationincrk
AT hornbeckpeter iterativetyrosinephosphorylationcontrolsnoncanonicaldomainutilizationincrk
AT machidakazuya iterativetyrosinephosphorylationcontrolsnoncanonicaldomainutilizationincrk
AT liutong iterativetyrosinephosphorylationcontrolsnoncanonicaldomainutilizationincrk
AT lihong iterativetyrosinephosphorylationcontrolsnoncanonicaldomainutilizationincrk
AT kalodimoscharalamposg iterativetyrosinephosphorylationcontrolsnoncanonicaldomainutilizationincrk
AT birgeraymondb iterativetyrosinephosphorylationcontrolsnoncanonicaldomainutilizationincrk